Biotechnology Division, CSIR-Institute of Himalayan Bioresource Technology, Palampur 176061 (H.P.), India; Academy of Scientific & Innovative Research (AcSIR), CSIR-Institute of Himalayan Bioresource Technology, Palampur 176061 (H.P.), India.
J Nanosci Nanotechnol. 2019 Apr 1;19(4):1889-1907. doi: 10.1166/jnn.2019.16502.
In the modern era, research on the synthesis of nanoparticles (NPs) has been growing exponentially. Due to their small size together with extra-ordinary physico-chemical properties, a variety of NPs i.e., metallic, carbon-based, fluorescent, and polymer-based have been exploited in different fields such as tissue engineering, drug delivery, and various other therapeutic applications. Instead of multi-disciplinary applications of NPs, research dealing with the toxicity concerns and influence of such materials, on the public health, plants and environment is still in its infancy. NPs can cause damage at the cellular, sub-cellular, molecular and protein levels owing to their extremely small size, large surface area to volume ratio, shape, and surface functionality. The present review is aimed to provide wide-ranging information related to NPs toxicology, the mechanisms of action, routes of their entry into the body and probable impacts on human health. Understanding of NPs entry routes into the body entails further research so as to update policymakers and regulatory bodies about the toxicity concerns associated with these nanomaterials. Proper characterization of NPs, factors affecting uptake and toxicity of NPs, as well as an understanding of processes when NPs come in contact with living beings, is critical to estimate the possible hazards.
在现代,对纳米粒子(NPs)合成的研究呈指数级增长。由于其尺寸小,具有非凡的物理化学性质,各种 NPs,如金属、碳基、荧光和聚合物基,已在组织工程、药物输送和各种其他治疗应用等不同领域得到了应用。除了 NPs 的多学科应用外,关于此类材料对公众健康、植物和环境的毒性问题和影响的研究仍处于起步阶段。由于 NPs 极其微小的尺寸、大的表面积与体积比、形状和表面功能,它们会在细胞、亚细胞、分子和蛋白质水平造成损害。本综述旨在提供有关 NPs 毒理学、作用机制、进入人体途径和对人类健康可能产生的影响的广泛信息。了解 NPs 进入人体的途径需要进一步研究,以便向政策制定者和监管机构更新与这些纳米材料相关的毒性问题。对 NPs 进行适当的特性描述、影响 NPs 摄取和毒性的因素,以及了解 NPs 与生物体接触时的过程,对于评估可能的危害至关重要。
J Nanosci Nanotechnol. 2019-4-1
Adv Drug Deliv Rev. 2011-9-8
Rev Environ Contam Toxicol. 2014
Adv Drug Deliv Rev. 2012-9-6
Curr Med Chem. 2018
Front Bioeng Biotechnol. 2023-9-12
Pharmaceutics. 2023-3-22
Toxicol Res (Camb). 2023-1-31
Nanomaterials (Basel). 2021-12-16
Sci Rep. 2021-9-7
Materials (Basel). 2020-11-11